VIRMA and chronic myelogenous leukemia, BCR-ABL1 positive: demonstrated that the KIAA1429/m6A/YTHDF1 axis promotes chronic myeloid leukaemia (CML) cells’ proliferation and drug resistance by increasing RAB27B mRNA stability and expression.